Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q1 2020 · 10-Q
Revenue$183.24M$183.24M+12.4% vs Q1 2019 Net Income$14.40M$14.40M−17.3% vs Q1 2019 EPS Diluted$0.37$0.37−17.8% vs Q1 2019 Gross Profit$118,414,000+10.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flow$40,539,000+2.8% Free Cash Flowderived$30,014,000−14.9% Margins · derivedGross margin64.6%−1.4 pt vs Q1 2019
Operating margin18.2%+2.4 pt vs Q1 2019
Net margin7.9%−2.8 pt vs Q1 2019
ended Sep 30, 2019 · filed Nov 6, 2019 · 37 d after period end